Oncology Medical News about osteosarcoma

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Pre-treatment serum lactate dehydrogenase level is an important prognostic factor in high-grade extremity osteosarcoma
Clinical and Translational Oncology, 07/21/09

Gonzalez–Billalabeitia E et al. – In this series, the pre–treatment serum LDH level had an independent prognostic value for both PFS and OS in patients with high–grade localised extremity osteosarcoma. This measurement should be included in a large prospective prognostic series.

<< Previous
Twist expression promotes migration and invasion in...

Next >>
Hypofractionated radiotherapy for localised prostate cancer....